Medical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.
Institute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd, Shanghai, P.R. China.
BMC Pulm Med. 2024 Oct 14;24(1):515. doi: 10.1186/s12890-024-03333-x.
Previous studies have shown that patients with pre-existing chronic obstructive pulmonary diseases (COPD) were more likely to be infected with coronavirus disease (COVID-19) and lead to more severe lung lesions. However, few studies have explored the severity and prognosis of COVID-19 patients with different phenotypes of COPD.
The aim of this study is to investigate the value of the deep learning and radiomics features for the severity evaluation and the nucleic acid turning-negative time prediction in COVID-19 patients with COPD including two phenotypes of chronic bronchitis predominant patients and emphysema predominant patients.
A total of 281 patients were retrospectively collected from Hohhot First Hospital between October 2022 and January 2023. They were divided to three groups: COVID-19 group of 95 patients, COVID-19 with emphysema group of 94 patients, COVID-19 with chronic bronchitis group of 92 patients. All patients underwent chest computed tomography (CT) scans and recorded clinical data. The U-net model was pretrained to segment the pulmonary involvement area on CT images and the severity of pneumonia were evaluated by the percentage of pulmonary involvement volume to lung volume. The 107 radiomics features were extracted by pyradiomics package. The Spearman method was employed to analyze the correlation of the data and visualize it through a heatmap. Then we establish a deep learning model (model 1) and a fusion model (model 2) combined deep learning with radiomics features to predict nucleic acid turning-negative time.
COVID-19 patients with emphysema was lowest in the lymphocyte count compared to COVID-19 patients and COVID-19 companied with chronic bronchitis, and they have the most extensive range of pulmonary inflammation. The lymphocyte count was significantly correlated with pulmonary involvement and the time for nucleic acid turning negative (r=-0.145, P < 0.05). Importantly, our results demonstrated that model 2 achieved an accuracy of 80.9% in predicting nucleic acid turning-negative time.
The pre-existing emphysema phenotype of COPD severely aggravated the pulmonary involvement of COVID-19 patients. Deep learning and radiomics features may provide more information to accurately predict the nucleic acid turning-negative time, which is expected to play an important role in clinical practice.
先前的研究表明,患有慢性阻塞性肺疾病(COPD)的患者更容易感染冠状病毒病(COVID-19),并导致更严重的肺部病变。然而,很少有研究探讨 COPD 不同表型的 COVID-19 患者的严重程度和预后。
本研究旨在探讨深度学习和放射组学特征在 COPD 包括慢性支气管炎表型和肺气肿表型的 COVID-19 患者严重程度评估和核酸转阴时间预测中的价值。
本研究共回顾性收集了 2022 年 10 月至 2023 年 1 月期间呼和浩特市第一医院的 281 例患者,将其分为三组:COVID-19 组 95 例,COVID-19 合并肺气肿组 94 例,COVID-19 合并慢性支气管炎组 92 例。所有患者均行胸部 CT 扫描,并记录临床资料。使用 U-net 模型对 CT 图像上的肺部受累区域进行分割,通过肺部受累体积与肺体积的百分比评估肺炎的严重程度。使用 pyradiomics 包提取 107 个放射组学特征。采用 Spearman 法分析数据的相关性,并通过热图可视化。然后我们建立了一个深度学习模型(模型 1)和一个融合深度学习和放射组学特征的融合模型(模型 2)来预测核酸转阴时间。
与 COVID-19 患者和 COVID-19 合并慢性支气管炎患者相比,COVID-19 合并肺气肿患者的淋巴细胞计数最低,肺部炎症范围最广。淋巴细胞计数与肺部受累和核酸转阴时间显著相关(r=-0.145,P<0.05)。重要的是,我们的结果表明,模型 2 预测核酸转阴时间的准确率为 80.9%。
COPD 患者预先存在的肺气肿表型严重加重了 COVID-19 患者的肺部受累。深度学习和放射组学特征可能提供更多信息,有助于准确预测核酸转阴时间,有望在临床实践中发挥重要作用。